Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New drug approvals to watch out for in 2015

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration approved more new molecular entities in 2014 than it had done in any year since 19961, but what should we expect for 2015? Here Scrip Intelligence takes a look at ten of the more interesting new products that are set for approval in the US and/or the EU over the coming 12 months.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS118060

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel